A New Paradigm in Permanent Contraception

Our Mission

Empower women with improved means to manage their reproductive health by providing access to patient-focused, safe, non-surgical, reliable permanent contraception.


In the US per annum


women no longer intend to have children


of annual 6 Million pregnancies are unintended


women use non permanent birth control long term


endometrial ablations annually


women undergo tubal ligation each year


of women surveyed would consider AltaSeal®

Permanent Contraception
Current standard of care: Tubal Ligation

What is Tubal Ligation?

Tubal ligation is a type of permanent birth control where the fallopian tubes are cut, tied or blocked to permanently prevent pregnancy.

Around the world, circa 220 million women are currently relying on permanent contraception via surgical tubal ligation to avoid pregnancy.

Our Focus

For Women: To provide permanent contraception that is office-based and easily-accessible through a simple, effective, non-surgical procedure. 

For Health Service Providers: To provide an ambulatory out-patient procedure so that best-in-class care can be provided.


  • Office based procedure.
  • Permanent biocompatible metal implant.
  • Atraumatic & easy-to-use.
  • Placed in the fallopian tubes using a hysteroscope.
  • Implant blocks the fallopian tube and prevents pregnancy.
Currently no Hysteroscopic Permanent Contraceptive Device on the Market.

" AltaScience's innovation and product development in the women's health space has the potential to drive better care at a lower cost for women seeking permanent contraception. It is important that we continue to learn from patient experiences with earlier products and work to design, develop and research minimally invasive techniques with the potential to improve care "

Prof. Barbara Levy MD

Clinical Professor Obstetrics and Gynecology

George Washington University School of Medicine and Health Sciences

UCSD Health, California, USA

News and Upcoming Events

HIHI femtech call winner 2023

AltaScience announced as HIHI femtech call 2023 winner 

 LSI Emerging Medtech Summit

AltaScience CEO recently presented at the LSI Emerging Medtech Summit 

 User Study at rotunda hospital in partnership with HiHi